Business Context and Reporting Period
This Form 6-K filing by Check-Cap Ltd. (not Mbody AI Ltd.) was submitted on November 2, 2021. The registrant is a foreign private issuer based in Israel, reporting under Rule 13a-16 of the Securities Exchange Act of 1934. The filing serves to incorporate a press release regarding a patent grant into various registration statements.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report of a specific corporate event and does not contain financial statements or performance metrics.
Material Changes
The material change reported is the grant of a patent covering C-Scan's proprietary tracking technology in the United States and additional major market territories. This development was announced via a press release dated November 2, 2021.
Guidance, Outlook, and Risks
The filing incorporates the "Forward Looking Statements" from the attached press release by reference but does not explicitly detail specific financial guidance, management commentary on future performance, or a list of risks within the body of this Form 6-K. The primary focus is the legal and intellectual property milestone.
Investor Verification Checklist
- Verify the full text of the press release (Exhibit 99.1) to understand the scope of the granted patent.
- Confirm the specific "major market territories" covered by the patent grant beyond the U.S.
- Review the referenced registration statements (S-8 and F-3) to see how this patent grant impacts the company's capital raising or equity incentive plans.
- Check subsequent filings for any financial impact or commercialization plans related to the C-Scan technology.